Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Participation Type:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 8 of 8 from AIDS Vaccine 2009
2010 Scientific Strategic Plan of the Global HIV Vaccine Enterprise: An Opportunity for Feedback and Input
Alan Bernstein
Global HIV Vaccine Enterprise
Mitchell Warren
from AIDS Vaccine 2009 on 19 October 2009 1:30 PM-4:00 PM
Opening Session
Jean-François Delfraissy
French National Agency for Research on AIDS and Viral Hepatits (ANRS)
Alan Bernstein
Global HIV Vaccine Enterprise
Michel Kazatchkine
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Michel Sidibé
UNAIDS
The state of HIV prevention: how well are we doing in preventing HIV worldwide, and how can we do better?
Peter Piot
Institute for Global Health, Imperial College London
Partners, participants and problem-solvers: expanding from “informed consent” to “informed communities” in the search for an AIDS vaccine
Mitchell Warren
AVAC
from AIDS Vaccine 2009 on 19 October 2009 5:00 PM-6:30 PM
Special Session: Recent Lessons from Clinical Trials
Chair: Margaret (Peggy) Johnston
Chair: Joep Lange
AIDS vaccine clinical evaluation: where are we and where can we go?
Gary Nabel
NIAID, NIH
Clinical outcomes from the STEP study
Susan Buchbinder
San Francisco Department of Public Health
Recent immunologic findings from the Step and related HIV vaccine clinical trials
Nicole Frahm
HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center and University of Washington
Interim efficacy analysis of HVTN 503/Phambili: a phase IIB test of concept trial of the MRKAd5 HIV-1 gag/pol/nef vaccine conducted in HIV-1 uninfected adults in South Africa
Glenda Gray
Perinatal HIV Research Unit, University of Witwatersrand
from AIDS Vaccine 2009 on 20 October 2009 8:30 AM-10:00 AM
Thai Trial Special Session
Chair: Margaret (Peggy) Johnston
Chair: Joep Lange
Phase III trial of HIV prime-boost vaccine combination in Thailand: result of final analysis
Supachai Rerks-Ngarm
Department of Disease Control, Ministry of Public Health
Primary and Subgroup Analyses of the Thai Phase III HIV Vaccine Trial
Nelson L. Michael
U.S Military HIV Research Program
Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boost vaccination in RV144, the Thai phase III HIV vaccine trial
Mark de Souza
U.S Military HIV Research Program/AFRIMS
from AIDS Vaccine 2009 on 20 October 2009 10:00 AM-10:50 AM
Plenary 01: Initiation of the Immune Response
Chair: Juliana McElrath
Chair: Rafick-Pierre Sékaly
Innate control of adaptive immunity to vaccines and pathogens
Bali Pulendran
Emory Vaccine Center
Harnessing human dendritic cell subsets for HIV vaccines
Jacques Banchereau
Baylor Institute for Immunology Research INSERM Unit #U899
T cell control and viral escape
Philip Goulder
University of Oxford
from AIDS Vaccine 2009 on 20 October 2009 11:00 AM-12:30 PM
Plenary 02: In vivo Responses to Pathogens & Vaccines
Chair: Jonathan Heeney
Chair: Andrew McMichael
In vivo dynamics of the immune response as revealed by multiphoton imaging
Ronald Germain
Laboratory of Immunology, NIAID, NIH
Efficacy of CMV/SIV vectors
Louis Picker
Vaccine and Gene Therapy Institute/Oregon Health & Science University
TB vaccine development
Jerald Sadoff
Aeras Global TB Vaccine Foundation
from AIDS Vaccine 2009 on 21 October 2009 9:00 AM-10:30 AM
Plenary 03: B-Cell Biology
Chair: Barton Haynes
Chair: Wayne Koff
Development of anti-HIV antibodies in humans with high titers of broadly neutralizing antibodies
Michel Nussenzweig
Howard Hughes Medical Institute, The Rockefeller University
From antibody to vaccine – a tale of structural biology and epitope scaffolds
Peter Kwong
Vaccine Research Center, NIAID/NIH
Induction and function of the mucosal immune system
Per Brandtzaeg
Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), University of Oslo, Division of Pathology, Oslo University Hospital Rikshospitalet
from AIDS Vaccine 2009 on 22 October 2009 9:00 AM-10:30 AM
Closing Session and Handover
Chair: Yves Levy
Chair: Giuseppe Pantaleo
Chair: Jack Whitescarver
HIV Vaccinology: What Does the Future Hold?
Anthony Fauci
National Institute of Allergy and Infectious Diseases
Are we targeting the right HIV determinants?
Françoise Barré-Sinoussi
Institut Pasteur
Closing Remarks and Handover
Yves Levy
French National Agency for Research on AIDS and Viral Hepatits (ANRS)
AIDS Vaccine 2010
Eric Hunter
Emory University
from AIDS Vaccine 2009 on 22 October 2009 12:00 PM-1:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 sessions: 1 to 8 of 8 from AIDS Vaccine 2009